PMID: 42557440

Telmisartan, P-glycoprotein inhibition, and bleeding risk in DOAC-treated patients with atrial fibrillation.

Tomita Hirofumi, Niioka Takenori

Hypertension research : official journal of the Japanese Society of Hypertension · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.